List view / Grid view


Genticel business update – fourth quarter 2014

28 January 2015 | By Genticel

Genticel, a French biotechnology company and leading developer of therapeutic vaccines, announces its cash ans cash equivalents and liquid investments position and its highlights from the fourth quarter of 2014...

ORYZON appoints Greg Weaver as Global Chief Financial Officer

12 January 2015 | By Oryzon

Oryzon Genomics SA, a clinical stage biopharmaceutical company developing therapeutics in oncology and CNS diseases based on its proprietary epigenetics technology platform, announced the appointment of Gregory L. Weaver as Executive Vice President and Chief Financial Officer, effective January 12, 2015...